Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
VERO Stock Summary
Top 10 Correlated ETFs
VERO
In the News

Venus Concept Inc. (VERO) Q1 2023 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO ) Q1 2023 Earnings Conference Call May 15, 2023 8:00 AM ET Company Participants Rajiv De Silva - CEO Hemanth Varghese - President & Chief Innovation and Business Officer Domenic Della Penna - CFO Conference Call Participants Destiny Hance - Ladenburg Thalmann Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2023 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.

Venus Concept to Release First Quarter of Fiscal Year 2023 Financial Results on May 15, 2023
TORONTO, April 11, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2023 financial results will be released before the market opens on Monday, May 15, 2023.

Venus Concept Inc. (VERO) Q4 2022 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO ) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Innovation and Business Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Anthony Vendetti - Maxim Group Jeffrey Cohen - Ladenburg Thalmann Operator Good day ladies and gentlemen and welcome to the Fourth Quarter 2022 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.

Trading Penny Stocks? Top Technical Analysis Tips
Can this help you to make money with penny stocks? The post Trading Penny Stocks?

Why Is Venus Concept (VERO) Stock Up 81% Today?
Venus Concept (NASDAQ: VERO ) stock is rocketing higher on Wednesday following approval for its fractional skin resurfacing technology. The U.S. Food and Drug Administration (FDA) has signed off on the company's surgical robotic technology platform called AI.ME.

Why Venus Concept (VERO) Shares Are Trading Higher Premarket Today? - Venus Concept (NASDAQ:VERO)
� 2022 Benzinga.com. Benzinga does not provide investment advice.

Best Penny Stocks To Buy Now? 7 Insider Picks In November
7 penny stock picks from insiders in November 2022 The post Best Penny Stocks To Buy Now? 7 Insider Picks In November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Penny Stocks To Buy Now? 4 Insider Picks In November
Penny stock picks from insiders in November 2022. The post Best Penny Stocks To Buy Now?

Activist Masters Capital Double Position in Venus Concept (VERO)
Fintel reports that Masters Capital Management Llc has filed a 13D/A form with the SEC disclosing ownership of 22,999,173 shares of Venus Concept Inc (VERO).

Venus Concept Inc. (VERO) Q3 2022 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO ) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Corporate Participants Rajiv De Silva - Chief Executive Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Jeff Cohen - Ladenburg Thalmann Marie Thibault - BTIG Anthony Vendetti - Maxim Group Operator Good day, ladies and gentlemen and welcome to the Third Quarter 2022 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.
VERO Financial details
VERO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 9.83 | 194.45 | 31.95 | 1.94 | 1.51 | |
Net income per share | -12.86 | -74.49 | -33.92 | -0.41 | -0.66 | |
Operating cash flow per share | -12.85 | -69.73 | -11.73 | -0.36 | -0.41 | |
Free cash flow per share | -13.3 | -71.71 | -11.85 | -0.37 | -0.41 | |
Cash per share | 7.22 | 27.59 | 14.05 | 0.57 | 0.18 | |
Book value per share | 0.71 | 130.64 | 18.12 | 0.75 | 0.12 | |
Tangible book value per share | 0.71 | 47.36 | 10.2 | 0.48 | -0.05 | |
Share holders equity per share | 0.71 | 130.64 | 18.12 | 0.75 | 0.12 | |
Interest debt per share | 9.71 | 134.85 | 36.02 | 1.52 | 1.34 | |
Market cap | 219.17M | 40.03M | 63.36M | 1.39B | 316.61M | |
Enterprise value | 222.52M | 93.38M | 108.67M | 1.44B | 388.81M | |
P/E ratio | -7.63 | -0.95 | -0.77 | -62.73 | -7.26 | |
Price to sales ratio | 9.98 | 0.36 | 0.81 | 13.15 | 3.18 | |
POCF ratio | -7.64 | -1.01 | -2.21 | -70.25 | -11.73 | |
PFCF ratio | -7.38 | -0.98 | -2.19 | -68.48 | -11.59 | |
P/B Ratio | 138.54 | 0.54 | 1.43 | 33.92 | 39.12 | |
PTB ratio | 138.54 | 0.54 | 1.43 | 33.92 | 39.12 | |
EV to sales | 10.13 | 0.85 | 1.39 | 13.59 | 3.91 | |
Enterprise value over EBITDA | -8.68 | -4.6 | -2.69 | -81.85 | -12.78 | |
EV to operating cash flow | -7.75 | -2.36 | -3.79 | -72.63 | -14.41 | |
EV to free cash flow | -7.49 | -2.29 | -3.75 | -70.79 | -14.23 | |
Earnings yield | -0.13 | -1.06 | -1.31 | -0.02 | -0.14 | |
Free cash flow yield | -0.14 | -1.02 | -0.46 | -0.01 | -0.09 | |
Debt to equity | 18.58 | 1.54 | 2.64 | 2.74 | 14.41 | |
Debt to assets | 0.95 | 0.6 | 0.73 | 0.73 | 0.93 | |
Net debt to EBITDA | -0.13 | -2.63 | -1.12 | -2.68 | -2.37 | |
Current ratio | 3.14 | 2.07 | 3.55 | 3.43 | 2.12 | |
Interest coverage | -11.65 | -2.69 | -4.85 | -3.54 | -7.65 | |
Income quality | 1 | 0.94 | 0.35 | 0.89 | 0.62 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.4 | 0.43 | 0.74 | 0.43 | 0.5 | |
Research and developement to revenue | 0.38 | 0.07 | 0.1 | 0.08 | 0.11 | |
Intangibles to total assets | 0 | 0.26 | 0.12 | 0.1 | 0.1 | |
Capex to operating cash flow | 0.04 | 0.03 | 0.01 | 0.03 | 0.01 | |
Capex to revenue | -0.05 | -0.01 | 0 | 0 | 0 | |
Capex to depreciation | -1.24 | -0.55 | -0.06 | -0.11 | -0.08 | |
Stock based compensation to revenue | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 | |
Graham number | 14.31 | 467.93 | 117.58 | 2.62 | 1.35 | |
ROIC | 5.1 | -0.14 | -0.48 | -0.19 | -0.36 | |
Return on tangible assets | -0.93 | -0.3 | -0.58 | -0.16 | -0.38 | |
Graham Net | -2.5 | -79.48 | -13.93 | -0.66 | -0.99 | |
Working capital | 20.11M | 51.53M | 82.89M | 75.78M | 44.41M | |
Tangible asset value | 1.58M | 26.89M | 24.9M | 26.2M | -3.18M | |
Net current asset value | 100K | -14.75M | -1.36M | -5.28M | -32.63M | |
Invested capital | 12.31 | 0.93 | 1.8 | 1.9 | 10.35 | |
Average receivables | 5.22M | 32.77M | 55.87M | 49.84M | 42.09M | |
Average payables | 2.93M | 6.61M | 7.86M | 5.62M | 6.47M | |
Average inventory | 4.14M | 12.18M | 18.3M | 19.15M | 22.22M | |
Days sales outstanding | 109.2 | 194.98 | 246.86 | 162.14 | 136.69 | |
Days payables outstanding | 111.85 | 101.66 | 86.67 | 56.88 | 87.46 | |
Days of inventory on hand | 161.89 | 203.78 | 243.48 | 237.83 | 260.27 | |
Receivables turnover | 3.34 | 1.87 | 1.48 | 2.25 | 2.67 | |
Payables turnover | 3.26 | 3.59 | 4.21 | 6.42 | 4.17 | |
Inventory turnover | 2.25 | 1.79 | 1.5 | 1.53 | 1.4 | |
ROE | -18.16 | -0.57 | -1.87 | -0.54 | -5.39 | |
Capex per share | -0.45 | -1.98 | -0.12 | -0.01 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.41 | 0.43 | 0.33 | 0.34 | 3.93 | |
Net income per share | -0.13 | -0.16 | -0.22 | -0.14 | -1.84 | |
Operating cash flow per share | -0.19 | -0.11 | -0.06 | -0.05 | -1.13 | |
Free cash flow per share | -0.2 | -0.12 | -0.06 | -0.05 | -1.14 | |
Cash per share | 0.28 | 0.16 | 0.1 | 0.16 | 1.23 | |
Book value per share | 0.51 | 0.36 | 0.14 | 0.11 | -0.17 | |
Tangible book value per share | 0.3 | 0.15 | -0.04 | -0.05 | -2.16 | |
Share holders equity per share | 0.51 | 0.36 | 0.14 | 0.11 | -0.17 | |
Interest debt per share | 1.23 | 1.22 | 1.21 | 1.21 | 16.28 | |
Market cap | 1.37B | 446.15M | 430.68M | 337.93M | 17.16M | |
Enterprise value | 1.43B | 513.12M | 501.52M | 410.13M | 94.18M | |
P/E ratio | -39.73 | -10.61 | -7.43 | -8.5 | -0.45 | |
Price to sales ratio | 51.98 | 16.36 | 20 | 13.91 | 0.84 | |
POCF ratio | -110.48 | -61.21 | -111.58 | -99.19 | -2.91 | |
PFCF ratio | -109.1 | -60.43 | -110.26 | -98.07 | -2.88 | |
P/B Ratio | 41.86 | 19.54 | 46.09 | 41.76 | -19.36 | |
PTB ratio | 41.86 | 19.54 | 46.09 | 41.76 | -19.36 | |
EV to sales | 54.24 | 18.82 | 23.28 | 16.89 | 4.59 | |
Enterprise value over EBITDA | -226.07 | -85.31 | -48.48 | -46.14 | -13.18 | |
EV to operating cash flow | -115.27 | -70.4 | -129.93 | -120.38 | -15.99 | |
EV to free cash flow | -113.84 | -69.5 | -128.4 | -119.02 | -15.81 | |
Earnings yield | -0.01 | -0.02 | -0.03 | -0.03 | -0.56 | |
Free cash flow yield | -0.01 | -0.02 | -0.01 | -0.01 | -0.35 | |
Debt to equity | 3.39 | 4.79 | 11.84 | 14.41 | -127.56 | |
Debt to assets | 0.77 | 0.82 | 0.92 | 0.93 | 1 | |
Net debt to EBITDA | -9.41 | -11.13 | -6.85 | -8.12 | -10.77 | |
Current ratio | 3.33 | 3.14 | 2.74 | 2.12 | 2.15 | |
Interest coverage | -8.06 | -6.89 | -9.37 | -6.42 | -5.41 | |
Income quality | 1.44 | 0.69 | 0.27 | 0.34 | 0.61 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.5 | 0.52 | 0.66 | 0.53 | 0.54 | |
Research and developement to revenue | 0.08 | 0.09 | 0.12 | 0.11 | 0.13 | |
Intangibles to total assets | 0.1 | 0.1 | 0.11 | 0.1 | 0.1 | |
Capex to operating cash flow | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to revenue | -0.01 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.14 | -0.08 | -0.04 | -0.03 | -0.07 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | |
Graham number | 1.25 | 1.15 | 0.85 | 0.6 | 2.65 | |
ROIC | -0.07 | -0.07 | -0.11 | -0.09 | -0.09 | |
Return on tangible assets | -0.07 | -0.09 | -0.13 | -0.09 | -0.09 | |
Graham Net | -0.68 | -0.79 | -0.91 | -0.93 | -12.63 | |
Working capital | 68.83M | 60.39M | 51.25M | 44.41M | 41.54M | |
Tangible asset value | 18.89M | 9.73M | -2.78M | -3.18M | -11.27M | |
Net current asset value | -12.57M | -20.79M | -29.85M | -32.63M | -35.27M | |
Invested capital | 2.36 | 3.39 | 8.31 | 10.35 | -94.17 | |
Average receivables | 50.89M | 50.86M | 46.2M | 40.04M | 38.2M | |
Average payables | 4.85M | 4.49M | 5.14M | 7.06M | 7.77M | |
Average inventory | 20.93M | 21.84M | 23.3M | 24.07M | 23.29M | |
Days sales outstanding | 177.66 | 163.67 | 178.87 | 138.09 | 171.61 | |
Days payables outstanding | 49.86 | 45.81 | 67.15 | 85.09 | 98.94 | |
Days of inventory on hand | 222 | 244.85 | 267.17 | 253.21 | 298.68 | |
Receivables turnover | 0.51 | 0.55 | 0.5 | 0.65 | 0.52 | |
Payables turnover | 1.81 | 1.96 | 1.34 | 1.06 | 0.91 | |
Inventory turnover | 0.41 | 0.37 | 0.34 | 0.36 | 0.3 | |
ROE | -0.26 | -0.46 | -1.55 | -1.23 | 10.86 | |
Capex per share | 0 | 0 | 0 | 0 | -0.01 |
VERO Frequently Asked Questions
What is Venus Concept Inc. stock symbol ?
Venus Concept Inc. is a CA stock , located in Toronto of On and trading under the symbol VERO
What is Venus Concept Inc. stock quote today ?
Venus Concept Inc. stock price is $2.2799 today.
Is Venus Concept Inc. stock public?
Yes, Venus Concept Inc. is a publicly traded company.